BioSpace News Archive

ZanthoSyn® Sales 4x Higher Than Q2 2017

Citius Pharmaceuticals a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced the closing of the previously announced underwritten at-the-market offering of 7,843,138 shares of its common stock and common warrants to purchase up to an aggregate of 7,843,138 shares of Common Stock.

Concordia International Corp. announced today that in connection with the previously announced recapitalization transaction (the “Recapitalization Transaction”) to be implemented pursuant to Concordia’s plan of arrangement under the Canada Business Corporations Act

In January 2016, AHF filed a federal lawsuit against Gilead Sciences, Inc. and two other defendants alleging drug patent manipulation and anti-trust claims regarding slightly different formulations of tenofovir, a key HIV/AIDS drug found in Gilead’s all-in-one Fixed Dose Combination HIV/AIDS treatments.

Mutual of America and its Boards of Directors, together with its officers, employees and retired employees, mourn the passing of Thomas J. Moran, Chairman Emeritus of Mutual of America, who passed away peacefully on Sunday, August 12, 2018.

Centro de Imagem Diagnósticos S.A. announces today its results for the second quarter of 2018 (2Q18).

Commercial production utilizing flow chemistry began June 2018 at Kaneka Singapore

Brea Free Dental Day is scheduled for August 18, 2018

Aridis Pharmaceuticals, Inc. announced the pricing of its initial public offering of 2,000,000 shares of its common stock at a public offering price of $13.00 per share for total gross proceeds of $26.0 million

Zoetis Inc. announced that it has agreed to sell $1.5 billion of senior notes